Interest in the emergence of hematopoietic stem cells in the embryo has dramatically increased in the last few years. Due to refinements in cell culture methods and molecular biology techniques, the potential of a minute number of cells to undergo differentiation and renewal can now be determined and the earliest expression of genes specific for each lineage can be detected. Some years ago, the extra-embryonic cohort of primitive hematopoietic progenitors was demonstrated to be shortlived in the avian model, with evidence that adult hematopoiesis arises from intra-embryonic stem cells [3] . It is now known that definitive lymphohematopoietic stem cells -that is, those giving rise to myeloid cells and T and B lymphocytes -are independently generated within the embryo proper in mammals as well (reviewed in [1] ).
Two issues have been the focus of recent attention: the developmental relationship of endothelial cells and hematopoietic cells; and the mechanism responsible for the selection of the particular set of hematopoietic genes expressed at different times of development. A recent paper from Nishikawa and colleagues [4] presents some evidence in favor of endothelial cells with lymphohematopoietic potential in the mouse embryo. Another paper exploring the second issue suggests that definitive hematopoietic stem cells can be reprogrammed into primitive hematopoietic stem cells when re-introduced into an appropriate microenvironment [5] .
Endothelial cells can give rise to lymphohematopoietic cells
Both hematopoietic and endothelial cells are affected following the homozygous deletion of the gene encoding vascular endothelial growth factor receptor 2 (VEGF-R2) [6] . In addition, a mutation induced in zebrafish has led to the identification of the cloche gene, which is required for the differentiation of the two lineages [7] . A cogent argument for a common precursor of these two cell typesthe so-called hemangioblast -is also derived from the experimental fate of cells in the very early avian blastodisc that express VEGF-R2 [8] . When cultured in a plasmabased semi-solid medium, these cells (but not those that lack VEGF-R2 expression) gave rise to hematopoietic colonies. The addition of VEGF to the medium induced the appearance of endothelial colonies while decreasing the number of hematopoietic colonies. When a soluble form of VEGF-R2 was added to the medium, hematopoietic colonies disappeared altogether. Strikingly, in none of the culture conditions used were mixed colonies containing both endothelial and hematopoietic cells ever observed, thus making direct identification of the hemangioblast impossible.
Nishikawa and colleagues [4, 9] undertook to document the surface phenotype of lymphohematopoietic precursors as they appear during mouse development. These precursors were found to express the cell adhesion molecule VE-cadherin (VE-cad), which has been reported to be an exclusive marker of endothelial cells. These VEcad-expressing (VE-cad + ) cells, which represent a small fraction of the VEGF-R2 + cells, are already organized in a tubular network, an obvious criterion of endothelial differentiation. VE-cad + cells from embryonic day 8.5 (E8.5) embryos gave rise to monocytic and granulocytic colonies in the appropriate culture conditions, while cells from E9.5 (but not E8.5) embryos or yolk sacs gave rise to B lymphocytes when cultured on the OP9 stromal cell line with interleukin-7, or to T lymphocytes when cultured in thymocyte-depleted thymic lobes. Nishikawa and colleagues conclude that the VE-cad + cells represent lymphohematopoietic endothelial cells, because the cells that are capable of giving rise to all hematopoietic lineages have an endothelial-specific phenotype ( Figure 1 ). These studies place the common endothelial/hematopoietic progenitor one step earlier on the differentiation pathway than previously identified by Keller's group using CD31 + , VEGF-R2 + cells sorted from embryonic stem cell derived embryonic bodies [10] . Furthermore, the progenitors identified by Nishikawa and colleagues [4] have been shown to have lymphoid potential as well as myeloid potential.
Interestingly, this expression pattern of cell surface markers on hematopoietic precursors in the embryo -established from cells which were taken from the mouse embryo, sorted and cultured in vitro -is in perfect agreement with an in situ tracking approach used to establish the origin of avian intraembryonic hematopoietic cells [11] . The fate of endothelial cells in the E2 aorta was followed after labeling these endothelial cells by the uptake of low density lipoproteins or by the integration of a retroviral vector bearing a marker gene. The hematopoietic cells, which typically emerge from the endothelial floor of the aorta at E3, bore the two markers. Furthermore, the endothelial floor at E2 expressed the endothelial-specific (or maybe hemangioblast-specific) antigen VEGF-R2, while at E3 it expressed the pan-leukocyte cell surface antigen CD45. Thus, in both mammalian and avian embryos, cells which were identified as endothelial cells were shown by different methods of analysis to switch to a hematopoietic fate. In both cases, the identification of intermediate steps in the commitment process will depend on the availability of molecular or cytological probes to distinguish between these steps.
Can definitive hematopoietic stem cells be reprogrammed?
The progenies of primitive, fetal and definitive hematopoietic stem cells express different sets of lineagespecific genes, such as globin genes or variable segments of the T-cell receptor. Albrecht Müller's group decided to investigate the mechanism of the genetic switches in successive generations of hematopoietic cells (Figure 2 ) by injecting adult bone marrow hematopoietic stem cells (which have the surface antigen phenotype Lin -, c-kit + , Sca-1 + ) into mouse blastocysts [5] . Erythroid progeny, identified as being derived from the injected adult cells by an array of markers, were found in the hematopoietic tissues of a significant proportion of recipients, at the embryonic, fetal, and adult stages of hematopoiesis. Chimeras were constructed with adult mouse bone marrow cells transgenic for a human β globin locus, which contains the embryonic (ε), fetal (γ), and adult (β) globin genes. The human genes expressed at different embryonic stages were then analyzed by the highly sensitive reverse transcription-based polymerase chain reaction (RT-PCR) approach to detect the ε, γ, and β globin genes. In E10.5 yolk sac and AGM, and in E11.5 and E12.5 yolk sac and fetal liver, the human ε and γ globin transgenes were transcribed. A weak β globin (adult) signal was detected in only 2 out of 16 chimeric E12.5 embryos. Thus, the authors concluded that the embryonic and fetal environment can reprogram adult hematopoietic stem cells to express embryonic and fetal genes.
A choice between fates is a usual occurrence in development. Thus, the problem has often been considered to be whether programming is imposed on responsive cells by the environment -'instructivity' -or whether survival factors are responsible for the selection of cells able to thrive in a particular environment -'permissivity'. Müller and colleagues favor the former possibility. Indeed, developmental choices between possible fates are known to be influenced by cell-cell contact mediated by ligand-receptor interactions. In the present experiments, Expression of various cell surface markers as cells undergo commitment to the hematopoietic pathway in the E8.5-9.5 mouse embryo [4, 9] . In particular, it is not clear whether lymphohematopoietic endothelial cells pass through a hemangioblast stage. Myeloid and lymphoid colonies were obtained by seeding lymphohematopoietic endothelial cells in distinct culture conditions. Intermediate differentiation stages were not documented by the experiments and are shown as dashed arrows. Note that the lymphohematopoietic endothelial cells express the endothelial-specific markers VE-cad and CD31. LDL, low density lipoprotein. however, the progenitors -sorted on the basis of Sca-1 and c-kit expression -are committed to the hematopoietic pathway and their genetic program is therefore likely to have already been selected. It is also important to bear in mind that a fraction of adult erythropoietic cells has often been demonstrated to express the embryonic or fetal program. These cells might be selected for in the embryonic environment, while the adult hematopoietic stem cells might not find the survival factors they require. It is nevertheless remarkable that some hematopoietic stem cells can survive for four days before the first hematopoietic microenvironment, namely the yolk sac, appears. In the yolk sac itself, it is likely that the range of available growth factors is different from that in hematopoietic organs that are functional at later stages of development, because primitive progenitors can survive in the absence of a number of hematopoietic-specific cytokines, such as kit ligand and erythropoietin. In (a,b) , it is still unknown whether the hemangioblast represents a distinct step. Progenitors with distinct lineage potentials have been found in the mouse embryo in the region designated as the paraaortic splanchnopleura (P-Sp) [12] or aorta-gonad-mesonephros (AGM) [13] at successive stages. In the avian embryo, hematopoietic cells bud into the vascular lumen from the floor of the aorta and later form prominent paraaortic foci in the dorsal mesentery. It seems clear that commitment of hematopoietic progenitors occurs in this region over several days. In my opinion, the change in potential is likely to occur as mesodermal cells become committed to the hematopoietic pathway (1), rather than during amplification of the earliest appearing progenitors (2). In the experiments by Müller and colleagues [5] , the cells that were back-transplanted into the blastocyst are the hematopoietic stem cells 
